Jason Aryeh, Director at Ligand Pharma, holds 24.55K shares in Lifecore Biomedical (Ticker: LFCR), holds 134.70K shares in Ligand Pharma (Ticker: LGND), holds 54.79K shares in Aralez Pharmaceuticals (Ticker: ARLZQ).
Jason Aryeh latest transaction was an Uninformative Buy of ―.
What was Jason Aryeh's most profitable transaction?
Jason Aryeh’s most profitable transaction was an Informative Buy of LGND stock on October 9, 2014. The return on the trade was 104.80%.
What is Jason Aryeh's role in Ligand Pharma?
Jason Aryeh's role in Ligand Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.